CatSci Ltd, an award-winning innovation partner for medicines development, will be attending DCAT Week, New York, on 17th – 20th March 2025.
Attending DCAT Week will be:
- Dr Simon Tyler, CatSci’s CCO and Co-Founder
- Dr Jas Douville, Head of Business Development, North America
With decades of experience, we consistently demonstrate the capacity to address common industry needs. From the pressures of accelerating timelines, managing resource constraints, and complex regulatory pathways, we understand these distinct challenges.
Our tailored solutions are designed to overcome these hurdles, enabling our clients to focus on delivering life-changing therapies to patients.
Why meet CatSci at DCAT Week:
- De-risk your pipeline through robust, phase-appropriate strategies
- Accelerate your path to clinic and commercial supply
- Streamline development with integrated CMC services
- Stay flexible to accommodate evolving project demands
Simon and Jas are looking forward to networking with the industry and exploring how CatSci can address your CMC challenges. Our in-depth drug development capabilities span across chemistry, route scouting, GMP-analytical, HPAPIs, material sciences and preformulation. We also have a dedicated start-of-the-art oligonucleotide facilities, which enables the synthesis of all classes of therapeutic oligos. Plus, through our acquisition of Reach Separations, Though our acquisition of Reach Separations, the world leaders in pharmaceutical preparative chromatography, you will get access to high quality solutions to your chromatographic and purification challenges.
Get in touch to Meet CatSci at DCAT 2025
To learn more or schedule a meeting, get in touch with us. Simon and Jas would love to discuss how our expertise and commitment can help you accelerate development and tackle CMC hurdles head-on.